Home > Financial Ratios > VENUS REMEDIES

VENUS REMEDIES
EV/Core EBITDA

    Back to All Ratios
VENUS REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

VENUS REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 3.815.752.905.004.89

What is the latest EV/Core EBITDA ratio of VENUS REMEDIES ?

The latest EV/Core EBITDA ratio of VENUS REMEDIES is 3.81 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar20253.81
Mar20245.75
Mar20232.90
Mar20225.00
Mar20214.89

How is EV/Core EBITDA of VENUS REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 3.81
-33.74
Mar2024 5.75
98.28
Mar2023 2.9
-42.00
Mar2022 5
2.25
Mar2021 4.89 -

Other Financial Ratios of VENUS REMEDIES


Compare EV/Core EBITDA ratio of peers of VENUS REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VENUS REMEDIES ₹865.6 Cr 14.4% 42.5% 92.7% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹428,077.0 Cr 2.8% 6.3% -1.1% Stock Analytics
DIVIS LABORATORIES ₹171,324.0 Cr -2.1% -2.5% 12.2% Stock Analytics
TORRENT PHARMACEUTICALS ₹126,235.0 Cr -2.5% 4.2% 21.5% Stock Analytics
CIPLA ₹123,294.0 Cr 0% -3.3% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹104,336.0 Cr 1.3% -0.5% -0.2% Stock Analytics


VENUS REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
VENUS REMEDIES

14.4%

42.5%

92.7%

SENSEX

0.9%

2.1%

8.3%


You may also like the below Video Courses